Chorionic Gonadotrophin
CAS No.: 9002-61-3 (Gonadotrophic hormone)

Short Description:

Source: Extracted from the urine of healthy pregnant women
Function and use: For women, it can promote the maturation and ovulation of follicles, and maintain the function of the corpus luteum. For men, it can stimulate the development of Leydig cells, increase androgen secretion, promote testicular descent and the development of male secondary sexual characteristics. Combined with urinary gonadotropin, it can simulate the physiological peak of luteinizing hormone and induce ovulation. Clinically, chorionic gonadotropin is still the drug of choice for the treatment of menstrual disorders, anovulatory infertility, threatened abortion and habitual live birth, cryptorchidism, and male sexual dysfunction.

Chorionic Gonadotrophin-Pharmacopoeia Standard: BP/EP

Send email to us

Product Detail

Product Tags

CAS No.: 9002-61-3
Complies with CP2020, USP43, BP2022, EP10.0

Specification

Chorionic Gonadotrophin
Source		Pregnant woman urine
Process description		Chorionic gonadotrophin is a dry preparation of placental glycoproteins which have luteinising activity. It is extracted from the urine of pregnant women.
Productionrequirements		This product should be extracted from healthy human urine. The production process should conform with the requirements of current version of Good Manufacturing Practice. It needs to undergo appropriate technological methods for virus safety control during the production process, so that any viruses such as hepatitis virus, human immunodeficiency virus, etc. can be removed or inactivated.
Pharmacopoeia standard		CP	EP/BP
Character		White or yellowish-White, amorphous powder. Soluble in water and insoluble in ethanol, acetone or ether.	White or yellowish-white, amorphous powder. Soluble in water.
Identification		When administered to immature rats as prescribed in the assay, it causes an increase in the mass of the seminal vesicles and of the prostate gland.	When administered to immature rats as prescribed in the assay, it causes an increase in the mass of the seminal vesicles and of the prostate gland.
Test	Residual solvent	Conform with regulation	_________
	Water	≤5%	maximum 5.0 per cent.
	Estrogen	Should not be positive	_________
	Abnormal toxicity	Conform with regulation	_________
	Bacterial endotoxin	≤0.01EU per IU of HCG	Less than 0.02 IU per IU of HCG
Potency	Chorionic gonadotrophin bioassay	Not less than 4500 IU/mg	Not less than 2500 IU/mg
Microbial limit	TAMC
	TYMC
Virus	Hbs Ag	Should be negative(10mg/ml)	_________
	HCV antibodies	_________
	HIV I+II	_________
Storage		In an airtight, tamper-proof container, protected from light. Preserved at cold place.	In an airtight, tamper-proof container, protected from light at a temperature of 2 °C to 8 °C.
Category		Gonadotropin drugs
Preparation		Chorionic Gonadotrophin for injection